Follicular lymphoma presenting with hypercalcaemia: An unusual mechanism of hypercalcaemia

P. Martens, B. Addissie, R. Kumar

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Hypercalcaemia is a frequent finding in patients with cancer. In up to 30% of malignancies, the disease course is complicated with hypercalcaemia. For hospitalized patients, cancer is the most common cause of hypercalcaemia. In normal physiological circumstances, the ionized calcium is kept in check by the influence of two important hormones, parathyroid hormone (PTH) and 1,25-dihydroxyvitamin D (1,25(OH)2D). However, cancer can misbalance the calcium homeostasis by generating certain humoural mediators. Overproduction of parathyroid hormone-related peptide (PTH-rp), intact PTH, 1,25(OH)2D, and cytokines all cause hypercalcaemia. Hypercalcaemia is frequent in certain haematological cancers such as multiple myeloma and aggressive lymphomas. But hypercalcaemia is rare in patients with indolent lymphomas such follicular lymphoma. This case illustrates as a first to our knowledge the involvement of cytokines and chemokines in the pathophysiology of lymphoma-related hypercalcaemia. A pathophysio-logical mechanism is offered based upon the current understanding of cytokines and chemokines related to follicular lymphoma.

Original languageEnglish (US)
Pages (from-to)200-203
Number of pages4
JournalActa Clinica Belgica: International Journal of Clinical and Laboratory Medicine
Issue number3
StatePublished - Jun 2015


  • Hypercalcaemia
  • Indolent lymphoma
  • Pathophysiology

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Follicular lymphoma presenting with hypercalcaemia: An unusual mechanism of hypercalcaemia'. Together they form a unique fingerprint.

Cite this